Catherine Stapledon

Catherine Stapledon, PhD, is currently serving as an R&D Translational Scientist at Paradigm Biopharmaceuticals since September 2020, where responsibilities include preclinical experimental designs, project management, and regulatory compliance. Prior to this role, Catherine was a Research Officer and PhD Candidate at the University of Adelaide from February 2016 to September 2020, completing a research-focused PhD in bone cell biology. Additional experience includes teaching as a Research Placement Course Demonstrator, customer service at Bardot Pty Ltd, and logistical support at SA Health. Catherine holds a Doctor of Philosophy in Medicine, an Honours Degree in Orthopaedics and Trauma, and a Bachelor's Degree in Pathology/Experimental Pathology, all from the University of Adelaide.